1
|
Autologous mesenchymal stem cells foster revascularization of ischemic limbs in systemic sclerosis: a case report.
|
Ann Intern Med
|
2010
|
1.65
|
2
|
Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions.
|
Rheumatology (Oxford)
|
2010
|
1.16
|
3
|
Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro.
|
Ann Rheum Dis
|
2011
|
1.07
|
4
|
Flow-mediated vasodilation and carotid intima-media thickness in systemic sclerosis.
|
Ann N Y Acad Sci
|
2007
|
1.01
|
5
|
Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational study.
|
Ann Rheum Dis
|
2012
|
0.98
|
6
|
The pathogenesis of inflammatory muscle diseases: on the cutting edge among the environment, the genetic background, the immune response and the dysregulation of apoptosis.
|
Autoimmun Rev
|
2002
|
0.93
|
7
|
Serial QuantiFERON TB-gold in-tube testing during LTBI therapy in candidates for TNFi treatment.
|
J Infect
|
2012
|
0.89
|
8
|
Exercise Doppler echocardiography identifies preclinic asymptomatic pulmonary hypertension in systemic sclerosis.
|
Ann N Y Acad Sci
|
2007
|
0.88
|
9
|
Therapeutic challenges for systemic sclerosis: facts and future targets.
|
Ann N Y Acad Sci
|
2007
|
0.85
|
10
|
Reduced circulating levels of angiotensin-(1--7) in systemic sclerosis: a new pathway in the dysregulation of endothelial-dependent vascular tone control.
|
Ann Rheum Dis
|
2007
|
0.83
|
11
|
Melatonin is a safe and effective treatment for chronic pulmonary and extrapulmonary sarcoidosis.
|
J Pineal Res
|
2006
|
0.81
|